{"result": "(\"entity\"<|>FURSEMIDA<|>ORGANIZATION<|>Furosemide is a diuretic medication used to treat fluid retention and high blood pressure, often administered intravenously in patients with hyponatremia.)\n##\n(\"entity\"<|>SODIO<|>ORGANIZATION<|>Sodium is an essential electrolyte in the body, and its levels are critical for maintaining fluid balance and normal cellular function.)\n##\n(\"entity\"<|>GLUCOSADO<|>ORGANIZATION<|>Glucosado refers to a glucose solution used in medical treatments, particularly for patients who cannot take water freely.)\n##\n(\"entity\"<|>ALGORITMO MULTIDISCIPLINAR<|>EVENT<|>A multidisciplinary algorithm used for the management of patients with hyponatremia, particularly those receiving artificial nutrition.)\n##\n(\"relationship\"<|>FURSEMIDA<|>HIPONATREMIA<|>Furosemide is used as part of the treatment protocol for managing hyponatremia<|>8)\n##\n(\"relationship\"<|>SODIO<|>HIPONATREMIA<|>Sodium levels are crucial in the diagnosis and treatment of hyponatremia<|>9)\n##\n(\"relationship\"<|>GLUCOSADO<|>NUTRICIÓN ARTIFICIAL<|>Glucosado solution is necessary for patients receiving artificial nutrition to maintain hydration<|>7)\n##\n(\"relationship\"<|>ALGORITMO MULTIDISCIPLINAR<|>HIPONATREMIA<|>The multidisciplinary algorithm provides guidelines for the treatment of hyponatremia<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: aminasas80, como se ha\ndescrito en algún paciente con poliquistosis renal tra-\ntado con dosis de 120 mg/día. Aun así, no se reco-\nmienda su administración en pacientes con transami-\nnasas elevadas > 3 veces el límite superior de la\nnormalidad (ficha técnica).\n\nAplicación de los tratamientos del SIADH a los\npacientes con nutrición artificial\n\nEn los pacientes con nutrición artificial, la restricción\nhídrica no es aplicable durante la administración de la\nmisma. De tal manera que el tratamiento se limita úni-\ncamente al uso de furosemida intravenosa, junto al mí-\nnimo aporte de líquidos necesarios (concentrar la medi-\ncación endovenosa, la fórmula de la NE y si es posible la\nde NP) y al incremento del aporte de sodio (aporte mí-\nnimo de 136 mEq/día). Si a pesar de ello persiste la hi-\nponatremia, se puede administrar tolvaptán por sonda\nnasogástrica en los pacientes con NE y por vía oral en\nlos pacientes con NP. Para ello es imprescindible que el\npaciente con NP conserve la deglución y el primer tra-\nmo del duodeno. Según la recomendación de expertos,\nla administración de tolvaptán en pacientes con nutri-\nción artificial es segura y eficaz cuando se pauta si-\nguiendo las indicaciones del algoritmo multidisciplinar\nadaptado39, 81 junto a una perfusión del suero glucosa-\ndo. Esta solución glucosada es necesaria debido a que\nlos pacientes con nutrición artificial no disponen de la\ncapacidad de tomar agua libremente si desarrollan sed,\ny poder compensar así la acuaresis inicial. Salvo esta\n---\n812      BLOQUE: SOPORTE NUTRICIONAL AVANZADO\n\nconsideración, el resto del protocolo es idéntico al des-\ncrito previamente para pacientes sin nutrición artificial.\nEn la figura 4 se muestra el protocolo de inicio de tol-\nvaptán, adaptado del algoritmo multidisciplinar, en pa-\ncientes con nutrición artificial.\n\nTras la retirada de la nutrición artificial se debe re-\nevaluar de nuevo al paciente y si persiste la hiponatre-\nmia por SIADH, seleccionar el tratamiento más adecua-\ndo en función de las indicaciones recogidas en la\ntabla 6. En estos pacientes debe tenerse en cuenta su\nestado nutricional, ya que algunas terapias como la\nrestricción hídrica (< 0,5 litros) pueden dificultar una\ningesta adecuada y limitar el consumo de los suple-\nmentos orales39. Aunque en estos casos podrían admi-\nnistrarse las fórmulas más concentradas.\n\nFinalmente, en la figura 5 se resume el tratamiento de\nla hiponatremia ajustado al tipo y etiología de la misma\ndurante la administración de la nutrición artificial.\n\n## 6. Resumen\n\nLa hiponatremia (HipoNa) es el trastorno del meta-\nbolismo del agua más frecuente en la práctica clínica,\nsobre todo en pacientes hospitalizados y más aún en\npacientes con nutrición artificial. Independientemente\nde su frecuencia, esta alteración es importante por la\nmayor morbimortalidad que asocia, objetivada tam-\nbién en los pacientes con nutrición artificial. Respecto\na su tratamiento, en estudios observacionales se ha\n\nencontrado: una disminución de la mortalidad en la\nHipoNa grave tratada activamente y una atenuación\ndel riesgo de mortalidad en la corrección de la HipoNa\nleve. La corrección de la HipoNa solo se logra con el\ntratamiento ajustado al tipo y a la etiología de la mis-\nma. Por ello, es importante diagnosticar correctamente\nla HipoNa. A continuación se resumen los pasos a se-\nguir en el manejo adecuado de la HipoNa en los pa-\ncientes con nutrición artificial:\n\n1) Valorar la gravedad de la HipoNa. Si el paciente\n   presenta clínica neurológica grave administrar so-\n   lución salina hipertónica. En ausencia de grave-\n   dad neurológica, pautar el tratamiento en fun-\n   ción del tipo y etiología de la HipoNa.\n2) Valorar la volemia clínica del paciente. En función\n   de la exploración física clasificar la HipoNa en vo-\n   lémica, volémica o hipervolémica. Si existen du-\n   das, valorar la evolución de la urea y la creatina\n   con el descenso de la natremia: aumento (HipoNa\n   hipovolémica) y descenso (HipoNa hipervolémica).\n3) Historia clínica y estudio analítico de HipoNa\n   (iones-osmolalidad en plasma y en muestra aisla-\n   da de orina, cortisol basal y hormonas tiroideas).\n   En\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>TOLVAPTÁN<|>ORGANIZATION<|>Tolvaptán is a medication used for treating hyponatremia, particularly in patients with artificial nutrition.)\n##\n(\"entity\"<|>SIADH<|>EVENT<|>Syndrome of Inappropriate Antidiuretic Hormone secretion, a condition that can lead to hyponatremia.)\n##\n(\"entity\"<|>NUTRICIÓN ARTIFICIAL<|>EVENT<|>Artificial nutrition refers to the provision of nutrients through means other than oral intake, often used in patients unable to eat normally.)\n##\n(\"entity\"<|>HIPONATREMIA<|>EVENT<|>Hyponatremia is a condition characterized by low sodium levels in the blood, which can lead to serious health issues.)\n##\n(\"entity\"<|>PACIENTE<|>PERSON<|>A patient undergoing treatment for hyponatremia and receiving artificial nutrition.)\n##\n(\"relationship\"<|>TOLVAPTÁN<|>SIADH<|>Tolvaptán is used to treat hyponatremia caused by SIADH<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN ARTIFICIAL<|>HIPONATREMIA<|>Patients receiving artificial nutrition are at risk of developing hyponatremia<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>NUTRICIÓN ARTIFICIAL<|>The patient is receiving artificial nutrition as part of their treatment<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>HIPONATREMIA<|>The patient is being treated for hyponatremia<|>6)\n##\n(\"relationship\"<|>SIADH<|>HIPONATREMIA<|>SIADH can lead to the development of hyponatremia<|>7)\n<|COMPLETE|>"}]}